{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:35:37Z","timestamp":1785418537243,"version":"3.56.0"},"reference-count":37,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012320","name":"Otto von Guericke University Magdeburg","doi-asserted-by":"publisher","award":["VAT DE 811 640 443"],"award-info":[{"award-number":["VAT DE 811 640 443"]}],"id":[{"id":"10.13039\/501100012320","id-type":"DOI","asserted-by":"publisher"}]},{"award":["VAT DE 811 640 443"],"award-info":[{"award-number":["VAT DE 811 640 443"]}],"id":[{"id":"https:\/\/ror.org\/00ggpsq73","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Venous thromboembolism (VTE) remains a clinically relevant complication following major orthopaedic procedures, particularly total hip arthroplasty (THA), total knee arthroplasty (TKA), and fracture surgery. Although low-molecular-weight heparin (LMWH) and direct oral anticoagulants (DOACs) are widely regarded as standard pharmacological options, aspirin (acetylsalicylic acid, ASA) has gained renewed attention because of its low cost, oral administration, and favourable bleeding profile. However, the available evidence is heterogeneous, and its interpretation is complicated by differences in patient selection, timing and duration of prophylaxis, diagnostic methodology, aspirin dosing regimens, and the increasing adoption of modern fast-track arthroplasty pathways. Methods: A structured evidence-based review was conducted in accordance with PRISMA 2020 principles. PubMed, Embase, Web of Science, and the Cochrane Library were searched through September 2025 for randomised controlled trials (RCTs), major international clinical practice guidelines, and selected high-level studies relevant to the interpretation of aspirin-based orthopaedic thromboprophylaxis. Nine RCTs, four major guideline documents, and sixteen additional Level I\u2013II studies were included. Outcomes of interest were symptomatic deep vein thrombosis (DVT), pulmonary embolism (PE), major bleeding, and mortality. Risk of bias was assessed using the Cochrane ROB 2 framework. Owing to marked methodological heterogeneity, no formal pooled meta-analysis was undertaken. Results: The available RCT evidence suggests that aspirin may perform adequately within structured sequential or risk-stratified prophylaxis strategies, but not in all clinical settings. In arthroplasty, EPCAT II demonstrated non-inferiority of aspirin when introduced after an initial five-day course of rivaroxaban, whereas CRISTAL showed higher early symptomatic VTE rates when aspirin was used as sole primary prophylaxis from postoperative day 0. Importantly, thromboembolic events in CRISTAL occurred earlier in the aspirin cohort, supporting the concept that anticoagulant therapy remains important during the immediate postoperative hypercoagulable phase. In trauma surgery, PREVENT CLOT established non-inferiority of aspirin compared with LMWH for 90-day mortality; however, the predominantly young study population and the inclusion of upper-extremity fractures limit extrapolation to elderly hip fracture patients. Several smaller RCTs reported no major differences between aspirin and anticoagulants, but these studies were frequently underpowered and relied on less sensitive diagnostic strategies. Historical and contemporary guidelines remain heterogeneous, and evidence from modern fast-track arthroplasty pathways suggests that current trial-based conclusions may not be directly generalisable to short-duration prophylaxis settings. Conclusions: Aspirin may have a role in orthopaedic thromboprophylaxis when used within structured, risk-adapted or sequential protocols, particularly in standard-risk arthroplasty patients and selected trauma populations. However, current evidence does not support its universal use as sole primary prophylaxis in major orthopaedic surgery, especially during the early postoperative hypercoagulable phase or in high-risk patients. Furthermore, the available literature does not permit definitive recommendations regarding the optimal aspirin dose or duration of prophylaxis. The generalisability of the existing literature is further limited by methodological heterogeneity and by the absence of RCTs directly evaluating ultra-short anticoagulant regimens versus prolonged aspirin prophylaxis in modern fast-track arthroplasty. Further high-quality, standardised trials are required.<\/jats:p>","DOI":"10.3390\/jcm15124550","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:52:08Z","timestamp":1781229128000},"page":"4550","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aspirin for Venous Thromboembolism Prevention in Orthopaedic Surgery with Focus on Trauma and Arthroplasty: A Structured Evidence-Based Review of Randomised Trials, Guidelines, and Contemporary Practice Considerations"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2336-6684","authenticated-orcid":false,"given":"Christian","family":"Riediger","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, University Hospital Magdeburg, Otto-von-Guericke-University Magdeburg, 39106 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ferl","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, University Hospital Magdeburg, Otto-von-Guericke-University Magdeburg, 39106 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8904-3637","authenticated-orcid":false,"given":"Maria","family":"Sch\u00f6nrogge","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, University Hospital Magdeburg, Otto-von-Guericke-University Magdeburg, 39106 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"ref_1","first-page":"e278S","article-title":"Prevention of VTEin orthopedic surgery patients: Antithrombotic Therapy Prevention of Thrombosis 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Francis","year":"2012","journal-title":"Chest"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1302\/2058-5241.3.170018","article-title":"Thromboembolism prophylaxis in orthopaedics: An update","volume":"3","author":"Flevas","year":"2018","journal-title":"EFORT Open Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e2345883","DOI":"10.1001\/jamanetworkopen.2023.45883","article-title":"Venous Thromboembolism in Total Hip and Total Knee Arthroplasty","volume":"6","author":"Simon","year":"2023","journal-title":"JAMA Netw. Open."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.7326\/M21-1474","article-title":"Rivaroxaban Is Associated with Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants: A Nationwide Propensity Score-Weighted Study","volume":"174","author":"Ingason","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial","volume":"355","author":"Duncan","year":"2000","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13018-019-1296-5","article-title":"Blood management in fast-track orthopedic surgery: An evidence-based narrative review","volume":"14","author":"Maffulli","year":"2019","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/EJA.0000000000002010","article-title":"European guidelines on peri-operative venous thromboembolism prophylaxis: First update.: Chapter 3: Day surgery and fast-track surgery","volume":"41","author":"Llau","year":"2024","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2106\/JBJS.I.00511","article-title":"American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty","volume":"91","author":"Johanson","year":"2009","journal-title":"J. Bone Jt. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"New Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"CRISTAL Study Group, Sidhu, V.S., Kelly, T.L., Pratt, N., Graves, S.E., Buchbinder, R., Adie, S., Cashman, K., Ackerman, I., and Bastiras, D. (2022). Effect of Aspirin vs. Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial. JAMA, 328, 719\u2013727.","DOI":"10.1001\/jama.2022.13416"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Major Extremity Trauma Research Consortium (METRC), O\u2019Toole, R.V., Stein, D.M., O\u2019Hara, N.N., Frey, K.P., Taylor, T.J., Scharfstein, D.O., Carlini, A.R., Sudini, K., and Degani, Y. (2023). Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture. New Engl. J. Med., 388, 203\u2013213.","DOI":"10.1056\/NEJMoa2205973"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.arth.2013.05.025","article-title":"DVT prophylaxis after TKA: Routine anticoagulation vs. risk screening approach\u2014A randomized study","volume":"28","author":"Kulshrestha","year":"2013","journal-title":"J. Arthroplast."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13018-024-04622-1","article-title":"Incidence and influence factors of venous thromboembolism in traumatic rib fracture patient: A multicenter study","volume":"19","author":"Zhang","year":"2024","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s13018-022-03268-1","article-title":"Incidence and risk factors of preoperative deep vein thrombosis in patients with intertrochanteric fractures: A retrospective study","volume":"17","author":"Song","year":"2022","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s13018-021-02595-z","article-title":"The incidence and risk factors of deep venous thrombosis in lower extremities following surgically treated femoral shaft fracture: A retrospective case-control study","volume":"16","author":"Ren","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zheng, X., Nong, L., Song, Y., Han, L., Zhang, Y., Yin, Q., and Bian, Y. (2024). Comparison of efficacy and safety between aspirin and oral anticoagulants for venous thromboembolism prophylaxis after major orthopaedic surgery: A meta-analysis of randomized clinical trials. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1326224"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/jth.13566","article-title":"Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: A network meta-analysis","volume":"15","author":"Kapoor","year":"2017","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"20230760","DOI":"10.1515\/med-2023-0760","article-title":"Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery","volume":"18","author":"Wei","year":"2023","journal-title":"Open Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10195-023-00742-2","article-title":"Antithrombotic prophylaxis following total hip arthroplasty: A level I Bayesian network meta-analysis","volume":"25","author":"Migliorini","year":"2024","journal-title":"J. Orthop. Traumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/17453674.2017.1361131","article-title":"Comparative efficacy and safety of anticoagulants for prevention of venous thromboembolism after hip and knee arthroplasty","volume":"88","author":"Hur","year":"2017","journal-title":"Acta Orthop."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.surge.2021.03.004","article-title":"Tourniquet use during knee arthroplasty: A Bayesian network meta-analysis on pain, function, and thromboembolism","volume":"20","author":"Migliorini","year":"2022","journal-title":"Surgeon"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s13018-025-05867-0","article-title":"Perioperative blood loss of sequential administration of hemocoagulase Agkistrodon and Tranexamic acid for primary total knee arthroplasty: A randomized controlled trial","volume":"20","author":"Ju","year":"2025","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1186\/s13018-024-05087-y","article-title":"Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major orthopedic surgery: A meta-analysis of randomized controlled trials","volume":"19","author":"Zhu","year":"2024","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13018-019-1231-9","article-title":"A nested case-control study on the risk factors of deep vein thrombosis for Chinese after total joint arthroplasty","volume":"14","author":"Xu","year":"2019","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13018-018-0883-1","article-title":"Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis","volume":"13","author":"Wu","year":"2018","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_26","unstructured":"National Guideline Centre (UK) (2018). Venous Thromboembolism in Over 16s: Reducing the Risk of Hospital-Acquired Deep Vein Thrombosis or Pulmonary Embolism, National Institute for Health and Care Excellence (NICE)."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.5312\/wjo.v12.i8.555","article-title":"Thromboelastography in elective total hip arthroplasty","volume":"12","author":"Lee","year":"2021","journal-title":"World J. Orthop."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1749-799X-7-14","article-title":"Thromboprophylaxis in spinal surgery: A survey","volume":"7","author":"Bryson","year":"2012","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: Prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zhou, L.B., Wang, C.C., Zhang, L.T., Wu, T., and Zhang, G.-Q. (2023). Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: A prospective randomized study. BMC Musculoskelet. Disord., 24.","DOI":"10.1186\/s12891-022-06117-8"},{"key":"ref_31","first-page":"741","article-title":"Aspirin versus Rivaroxaban to Prevent Venous Thromboembolism after Total Knee Arthroplasty: A Double-blinded, Randomized Controlled Trial","volume":"57","author":"Hongnaparak","year":"2021","journal-title":"Rev. Bras. Ortop."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.rbo.2016.12.004","article-title":"Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): Aspirin vs. rivaroxaban","volume":"53","author":"Colleoni","year":"2017","journal-title":"Rev. Bras. De Ortop."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3760\/cma.j.issn.0366-6999.20132175","article-title":"Aspirin combined with mechanical measures to prevent venous thromboembolism after total knee arthroplasty: A randomized controlled trial","volume":"127","author":"Jiang","year":"2014","journal-title":"Chin. Med. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MBC.0000000000000121","article-title":"Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty","volume":"25","author":"Zou","year":"2014","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00003086-199603000-00031","article-title":"Aspirin and warfarin for thromboembolic disease after total joint arthroplasty","volume":"324","author":"Lotke","year":"1996","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s40520-023-02378-y","article-title":"Functional autonomy and 12-month mortality in older adults with proximal femoral fractures in an orthogeriatric setting: Risk factors and gender differences","volume":"35","author":"Ceolin","year":"2023","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Siviero, P., Marseglia, A., Biz, C., Rovini, A., Ruggieri, P., Nardacchione, R., and Maggi, S. (2020). Quality of life outcomes in patients undergoing knee replacement surgery: Longitudinal findings from the QPro-Gin study. BMC Musculoskelet. Disord., 21.","DOI":"10.1186\/s12891-020-03456-2"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4550\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:19:09Z","timestamp":1781230749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124550"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124550","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]}}}